Additionally, our findings suggest that drugs, dietary components, and gut microbiota metabolites antagonistic to AhR could contribute to IBD and CRC progression by increasing skatole-induced IL-6 and TNF-α expression. Here, IL6 is linked to inflammatory bowel disease.